Literature DB >> 11180097

Organization of plasma membrane functional rafts upon T cell activation.

L Tuosto1, I Parolini, S Schröder, M Sargiacomo, A Lanzavecchia, A Viola.   

Abstract

Raft microdomains have been shown to play a key role in T cell activation. We found that in human T lymphocytes the formation of functional rafts at the plasma membrane was induced by T cell priming. In resting T cells from peripheral blood Lck and the raft glycosphingolipid GM1 resided in intracellular membranes. T cell activation induced synthesis of GM1 and effector cells showed very high levels of this lipid, which became predominantly plasma membrane associated. TCR triggering also induced targeting of the cytosolic Lck to the plasma membrane. Thus, effector cells acquire an improved signaling machinery by increasing the amount of rafts at the plasma membrane. The fact that, when compared with naive T cells, memory T cells showed higher GM1 levels suggests that raft lipid synthesis may be developmentally regulated and tune T cell responsiveness.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11180097     DOI: 10.1002/1521-4141(200102)31:2<345::aid-immu345>3.0.co;2-l

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  37 in total

Review 1.  CD20-mediated apoptosis: signalling through lipid rafts.

Authors:  Julie P Deans; Haidong Li; Maria J Polyak
Journal:  Immunology       Date:  2002-10       Impact factor: 7.397

2.  Interplay between TCR affinity and necessity of coreceptor ligation: high-affinity peptide-MHC/TCR interaction overcomes lack of CD8 engagement.

Authors:  Samantha E Kerry; Jennifer Buslepp; Lorraine A Cramer; Robert Maile; Lucinda L Hensley; Alma I Nielsen; Paula Kavathas; Barbara J Vilen; Edward J Collins; Jeffrey A Frelinger
Journal:  J Immunol       Date:  2003-11-01       Impact factor: 5.422

Review 3.  CTLA-4 and tolerance: the biochemical point of view.

Authors:  Shunsuke Chikuma; Jeffrey A Bluestone
Journal:  Immunol Res       Date:  2003       Impact factor: 2.829

4.  Gene delivery by dendrimers operates via a cholesterol dependent pathway.

Authors:  Maria Manunta; Peng Hong Tan; Pervinder Sagoo; Kirk Kashefi; Andrew J T George
Journal:  Nucleic Acids Res       Date:  2004-05-17       Impact factor: 16.971

5.  Activation of naïve CD4 T cells by anti-CD3 reveals an important role for Fyn in Lck-mediated signaling.

Authors:  Katsuji Sugie; Myung-Shin Jeon; Howard M Grey
Journal:  Proc Natl Acad Sci U S A       Date:  2004-10-01       Impact factor: 11.205

6.  CD4 and CD8 T cells require different membrane gangliosides for activation.

Authors:  Masakazu Nagafuku; Kaori Okuyama; Yuri Onimaru; Akemi Suzuki; Yuta Odagiri; Tadashi Yamashita; Katsunori Iwasaki; Michihiro Fujiwara; Motoaki Takayanagi; Isao Ohno; Jin-ichi Inokuchi
Journal:  Proc Natl Acad Sci U S A       Date:  2012-01-17       Impact factor: 11.205

7.  Actin depolymerization transduces the strength of B-cell receptor stimulation.

Authors:  Shengli Hao; Avery August
Journal:  Mol Biol Cell       Date:  2005-02-23       Impact factor: 4.138

8.  Epitope-specific crosslinking of CD45 down-regulates membrane-associated tyrosine phosphatase activity and triggers early signalling events in human activated T cells.

Authors:  François Spertini; Veronique Perret-Menoud; Nathalie Barbier; Talal Chatila; Catherine Barbey; Blaise Corthesy
Journal:  Immunology       Date:  2004-12       Impact factor: 7.397

9.  Expression of GM1, a marker of lipid rafts, defines two subsets of human monocytes with differential endocytic capacity and lipopolysaccharide responsiveness.

Authors:  M Maximina Bertha Moreno-Altamirano; Israel Aguilar-Carmona; F Javier Sánchez-García
Journal:  Immunology       Date:  2007-01-22       Impact factor: 7.397

10.  Altered lipid raft-associated signaling and ganglioside expression in T lymphocytes from patients with systemic lupus erythematosus.

Authors:  Elizabeth C Jury; Panagiotis S Kabouridis; Fabian Flores-Borja; Rizgar A Mageed; David A Isenberg
Journal:  J Clin Invest       Date:  2004-04       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.